Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andra Balanescu

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Annals of the Rheumatic Diseases|November 17, 2018
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countriesClémence Gorlier, Ana-Maria Orbai, Déborah Puyraimond-Zemmour, et al.
Annals of the Rheumatic Diseases|May 3, 2014
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiativeLaure Gossec, Maarten de Wit, Uta Kiltz, et al.
Rheumatology (Oxford, England)|January 3, 2025
Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP studyClementina López-Medina, Clémence Gorlier, Ana-Maria Orbai, et al.
Rheumatology (Oxford, England)|June 3, 2025
Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohortStefano Di Donato, John D Pauling, Sheila Ramjug, et al.
Arthritis Care & Research|October 15, 2019
Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen CountriesAna-Maria Orbai, Jamie Perin, Clémence Gorlier, et al.
Annals of the Rheumatic Diseases|January 6, 2018
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritisHelga Radner, Katerina Chatzidionysiou, Elena Nikiphorou, et al.
Annals of the Rheumatic Diseases|October 30, 2025
EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritisHelena Marzo-Ortega, Stephanie R Harrison, George E Fragoulis, et al.
Arthritis Care & Research|June 15, 2026
Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study from the EUSTAR CohortStefano Di Donato, Marie-Elise Truchetet, Marco Minerba, et al.
Annals of the Rheumatic Diseases|May 22, 2020
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 updateLaure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases|March 18, 2024
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateLaure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Annals of the Rheumatic Diseases|November 17, 2018
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countriesClémence Gorlier, Ana-Maria Orbai, Déborah Puyraimond-Zemmour, et al.
Annals of the Rheumatic Diseases|May 3, 2014
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiativeLaure Gossec, Maarten de Wit, Uta Kiltz, et al.
Rheumatology (Oxford, England)|January 3, 2025
Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP studyClementina López-Medina, Clémence Gorlier, Ana-Maria Orbai, et al.
Rheumatology (Oxford, England)|June 3, 2025
Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohortStefano Di Donato, John D Pauling, Sheila Ramjug, et al.
Arthritis Care & Research|October 15, 2019
Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen CountriesAna-Maria Orbai, Jamie Perin, Clémence Gorlier, et al.
Annals of the Rheumatic Diseases|January 6, 2018
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritisHelga Radner, Katerina Chatzidionysiou, Elena Nikiphorou, et al.
Annals of the Rheumatic Diseases|October 30, 2025
EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritisHelena Marzo-Ortega, Stephanie R Harrison, George E Fragoulis, et al.
Arthritis Care & Research|June 15, 2026
Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study from the EUSTAR CohortStefano Di Donato, Marie-Elise Truchetet, Marco Minerba, et al.
Annals of the Rheumatic Diseases|May 22, 2020
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 updateLaure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases|March 18, 2024
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateLaure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, et al.
Pageof 6